SHORLA ONCOLOGY ANNOUNCES U.S. FDA APPROVAL OF NELARABINE INJECTION FOR THE TREATMENT OF T-CELL LEUKEMIA

Recent Press Releases

• ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse
• EVERSANA Unveils TEDAVI, the Breakthrough Content Creation Hub to Transform Agency Marketing Models and Maximize Brand Impact
• Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
• EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate
• EVERSANA and MyHealthTeam Launch Groundbreaking Direct-to-Patient Solution to Accelerate Time to Diagnosis and Treatment